KOPRAN
Back to Cashflow Statement
|
KOPRAN Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹0.99 Cr | ₹-20 Cr | ₹123 Cr | ₹-35 Cr | ₹-18 Cr |
What is the latest Cash Flow from Financing Activities ratio of KOPRAN ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹0.99 Cr |
Mar2023 | ₹-20 Cr |
Mar2022 | ₹123 Cr |
Mar2021 | ₹-35 Cr |
Mar2020 | ₹-18 Cr |
How is Cash Flow from Financing Activities of KOPRAN Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹0.99 Cr | Positive | |
Mar2023 | ₹-20 Cr | Negative | |
Mar2022 | ₹123 Cr | Positive | |
Mar2021 | ₹-35 Cr | Negative | |
Mar2020 | ₹-18 Cr | - |
Compare Cash Flow from Financing Activities of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹860.0 Cr | -1.5% | -11.6% | -33.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | -1.5% |
-11.6% |
-33.7% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses